Graphite

News

When it comes to enthusiasm about digital innovation, pharma seems to be more adept at talking the talk than walking the walk, as it were.

News

Viridian has fired a shot across Amgen's bows with the FDA approval of Tepezza rival Lumvoa in thyroid eye disease, a $2bn market.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.